Regeneus gets Japanese patent for Progenza stem cell technology

May 24 (Reuters) - Regeneus Ltd (RGS)

  • Announces Japanese patent office decision to grant key patent for Progenza stem cell technology
  • Progenza for treatment of osteoarthritis and other inflammatory conditions for human and animal applications


To read reuters' full disclaimer click here
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.